Direct-to-consumer pharmacogenomic testing

Author： Howard Heidi Carmen Borry Pascal

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.12, Iss.10, 2011-10, pp. : 1367-1370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Direct-to-consumer genome testing: opportunities for pharmacogenomics research?

By Prainsack Barbara Wolinsky Howard

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 651-655

Future Medicine

Access to resources Recommend Favorite

Predictive ability of direct-to-consumer pharmacogenetic testing: when is lack of evidence really lack of evidence?

By Kalf Rachel RJ Bakker Rachel Janssens A Cecile JW

Pharmacogenomics, Vol. 14, Iss. 4, 2013-03 ,pp. : 341-344

Future Medicine

Access to resources Recommend Favorite

Costs and Benefits of Direct-to-Consumer Advertising: The Case of Depression

By Block Adam E.

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 511-521

Adis International

Access to resources Recommend Favorite

Direct-to-consumer ads may be beneficial for aromatase inhibitors

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 668, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Little evidence for benefits with direct-to-consumer advertising

Inpharma, Vol. 1, Iss. 1582-1583, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite